here's a juicy section of the report:
"This story gives the image of a UCLA investigator exploring the effect of some new UCLA developed drug and discovering a breakthrough cure. Etanercept is not a UCLA drug, and it is not a new drug. Etanercept has been on the market for about a decade under the brand name Enbrel. As mentioned already, UCLA did not play any part in this case report.
Dr. Tobinick is not some UCLA neurological researcher. He is a dermatologist and internist in private practice in a laser hair removal clinic. As mentioned, his clinic is located in the UCLA Medical Plaza, which also houses the Institute for Neurologic Research, which is the medical group that treats patients with Dr. Tobinick’s Etanercept treatment."
No comments:
Post a Comment